Aronora, Inc.

Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and enzymes. Rational design of our innovative therapeutic agents is expected to result in drug products that reduce the progression and growth of life-threatening blood clots without the detrimental bleeding side effects that characterize all currently marketed antithrombotic drugs. Our products are intended to be used in difficult-to-treat, severe, rapidly progressing, or catastrophic thrombotic blood clotting diseases.

Website

http://aronorabio.com/

External link for Aronora, Inc.

Industry

Pharmaceutical Manufacturing

Company size

2-10 employees

Headquarters

Portland, Oregon

Type

Privately Held

Founded

2009

Specialties

hematology